Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Transforming Research and Clinical Knowledge in TBI Pilot

This study has been completed.
Sponsor:
Collaborator:
Information provided by (Responsible Party):
University of California, San Francisco
ClinicalTrials.gov Identifier:
NCT01565551
First received: March 24, 2012
Last updated: January 3, 2014
Last verified: January 2014
Results First Received: January 3, 2014  
Study Type: Observational
Study Design: Observational Model: Cohort;   Time Perspective: Prospective
Condition: Traumatic Brain Injury
Intervention: Other: N/A (Observational Study)

  Participant Flow
  Hide Participant Flow

Recruitment Details
Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations
No text entered.

Pre-Assignment Details
Significant events and approaches for the overall study following participant enrollment, but prior to group assignment
No text entered.

Reporting Groups
  Description
Early-Presenting TBI: Acute Sites

This cohort of patients are studied after acute presentation within 24 hours of TBI to one of the three TRACK-TBI acute Level I Trauma Centers (SFGH, UPMC, UMCB).

N/A (Observational Study): No Interventions: Observational Study

Late-Presenting TBI: Rehabilitation Center

This cohort of patients are studied after presentation to the TRACK-TBI rehabilitation site (MSMC).

N/A (Observational Study): No Interventions: Observational Study


Participant Flow:   Overall Study
    Early-Presenting TBI: Acute Sites     Late-Presenting TBI: Rehabilitation Center  
STARTED     586     51  
Clinical/Demographics     586     51  
Biospecimens/Biomarkers     479     22  
Neuroimaging     233     25  
6-Month Outcomes     412     30  
COMPLETED     586     51  
NOT COMPLETED     0     0  



  Baseline Characteristics
  Hide Baseline Characteristics

Population Description
Explanation of how the number of participants for analysis was determined. Includes whether analysis was per protocol, intention to treat, or another method. Also provides relevant details such as imputation technique, as appropriate.
No text entered.

Reporting Groups
  Description
Early-Presenting TBI: Acute Sites

This cohort of patients are studied after acute presentation within 24 hours of TBI to one of the three TRACK-TBI acute Level I Trauma Centers (SFGH, UPMC, UMCB).

N/A (Observational Study): No Interventions: Observational Study

Late-Presenting TBI: Rehabilitation Center

This cohort of patients are studied after presentation to the TRACK-TBI rehabilitation site (MSMC).

N/A (Observational Study): No Interventions: Observational Study

Total Total of all reporting groups

Baseline Measures
    Early-Presenting TBI: Acute Sites     Late-Presenting TBI: Rehabilitation Center     Total  
Number of Participants  
[units: participants]
  586     51     637  
Age  
[units: Years]
Mean ± Standard Deviation
  43.3  ± 18.5     49.9  ± 20.4     43.9  ± 18.7  
Gender  
[units: Participants]
     
Female     167     14     181  
Male     419     37     456  
Race (NIH/OMB)  
[units: Participants]
     
American Indian or Alaska Native     3     0     3  
Asian     22     2     24  
Native Hawaiian or Other Pacific Islander     17     0     17  
Black or African American     46     9     55  
White     471     39     510  
More than one race     21     0     21  
Unknown or Not Reported     6     1     7  
Ethnicity (NIH/OMB)  
[units: Participants]
     
Hispanic or Latino     84     5     89  
Not Hispanic or Latino     495     33     528  
Unknown or Not Reported     7     13     20  



  Outcome Measures

1.  Primary:   Glasgow Outcome Scale Extended (GOSE)   [ Time Frame: 6 Months Post-Injury ]


  Serious Adverse Events


  Other Adverse Events


  Limitations and Caveats
  Hide Limitations and Caveats

Limitations of the study, such as early termination leading to small numbers of participants analyzed and technical problems with measurement leading to unreliable or uninterpretable data
Enrolling patients representative of the TBI population created challenges for follow-up (e.g. homelessness, substance abuse); limited access to research MRI scanner; lack of validated outcome measures for non-English-speaking and pediatric patients.


  More Information
  Hide More Information

Certain Agreements:  
All Principal Investigators ARE employed by the organization sponsoring the study.


Results Point of Contact:  
Name/Title: Geoffrey Manley, MD, PhD
Organization: University of California, San Francisco
phone: 415-206-8300
e-mail: manleyg@neurosurg.ucsf.edu


Publications:
Foulkes AM, Eisenberg MH, Jane AJ. The Traumatic Coma Data Bank; design, methods and baseline characteristics. J. Neuroch. 75, S1-S15, 1991
Ng J, Wahl M, Tong L, Lee H, Veeraraghavan S, Xu D, Zhao S, Kornak J, Meeker M, Ghajar J, Manley GT, Mukherjee P. 3T Diffusion Tensor Imaging of Mild Traumatic Brain Injury: A Prospective Longitudinal Study. Proc ISMRM 2009; 641.

Publications automatically indexed to this study:


Responsible Party: University of California, San Francisco
ClinicalTrials.gov Identifier: NCT01565551     History of Changes
Other Study ID Numbers: RC2NS069409, RC2NS069409
Study First Received: March 24, 2012
Results First Received: January 3, 2014
Last Updated: January 3, 2014
Health Authority: United States: Federal Government
United States: Institutional Review Board